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Abstract 
 
COMPARISON OF WITHINGS BODYCARDIO TO GOLD STANDARD 
MEASUREMENTS OF PULSE-WAVE VELOCITY AND BODY COMPOSITON 
 
Conner A. McCraw 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson: Scott R. Collier, Ph.D. 
 
 
  Introduction: General Wellness Products (GWP) are widely used by consumers, 
human physiology scientists, and healthcare practitioners. However, current research on 
GWP accuracy is limited and often reports large inaccuracies. Purpose: The purpose of this 
study was to assess the Withings BodyCardio for accuracy in the measurement of body 
composition and arterial health when compared against gold standard laboratory 
measurements. Methods: Healthy, young males (N=10) and females (N=10) were assessed 
for measures of body composition and pulse-wave velocity (PWV) in a randomized order 
utilizing air displacement plethysmography (BodPod), applanation tonometry 
(SphygmoCor), and the Withings BodyCardio. Measures of body composition and PWV 
were compared with criterion measures using the Bland-Altman analysis and mean absolute 
percent error (MAPE). Results: Data is reported as Bias (95% Confidence Interval). The 
BodyCardio overestimated PWV by 0.68 m/s (-0.16, 1.51) and fat mass by 2.91 kg (-2.91, 
8.73). BodyCardio PWV and fat mass estimations had a MAPE of 9.7% and 25.8%, 
respectively. The BodyCardio underestimated body mass and fat-free mass by 0.11 kg (-0.41, 
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0.18) and 2.87 kg (-9.04, 3.30), respectively. BodyCardio body mass and fat-free mass 
estimations had a MAPE of 0.15% and 5.6%, respectively. Discussion: The Withings 
BodyCardio should be used cautiously for measures of fat mass and fat-free mass, although it 
provides accurate measures of body mass and PWV.  
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Chapter 1 
Introduction 
Background 
General Wellness Products (GWP) are increasingly made available to consumers by 
companies like Withings, Apple, and Fitbit. These sensory-based devices aim to objectively 
quantify a myriad of health-related measures such as physical activity, sleep, body 
composition, heart rate and derivative measures such as heart rate variability as well as pulse-
wave velocity (PWV). Technological and engineering advancements in accelerometry, 
photo-plethysmography, ballistocardiography, and bioelectric impedance analysis (BIA) are 
primarily responsible for the development of General Wellness Products, however the 
validity of these technologies have been questioned.  
 Digital bathroom scales, physical activity monitors and bedside sleep devices are 
commercially sold and were recently classified as “General Wellness Products” by the U.S. 
Food and Drug Administration’s amendment to the 21st Century Cures Act (FDA Digital 
Health, 2018). Their presence in the consumer market place is evident. A survey of 5,000 
U.S. adults reported that one out of ten owns a GWP with an expected 11% increase in use 
by the end of 2016” (Live Science, 2015). Research scientists in human physiology and 
behavioral sciences frequently use GWP’s as well. Analysis of clinicaltrials.gov in 2016 
revealed that Fitbit, the leading producer of GWP’s, was involved in one hundred and 
twenty-seven clinical studies (Wright, Hall Brown, Collier, & Sandberg, 2017). Research 
applications are outside of this study’s scope, however, Wright et al has provided an 
extensive review on how some GWP’s are transforming human physiology research (Wright 
et al., 2017). Additionally, data from GWP’s are being integrated into electronic medical 
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records and could be used to inform medical decisions which adds to the demand of validity 
assessment (Waggott, Singh, Batra, Wright, Ashley, 2016).  
Consumers, researchers, and healthcare practitioners could assume GWP’s are 
accurate, however, validation studies are often unavailable (Bassett, Rowlands, & Trost, 
2012). An issue with validating GWP’s is that new device models are increasingly available 
making it difficult for researchers to design, fund, and implement a validation study with the 
device still relevant. The validation studies that do exist often report large disagreements 
when GWP measurements are compared against gold-standard research laboratory 
measurements (Baroni, Bruzzese, Di Bartolo, & Shatkin, 2016; Nelson, Kaminsky, Dickin, & 
Montoye et al., 2016; Shcherbina et al., 2017).  
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Chapter 2 
Review of Literature 
Measurement of Body Composition  
 According to data from the National Health and Nutrition Examination Survey 
(NHANES) more than 2 in 3 U.S. adults are considered to be overweight or obese (BMI ≥ 25 
kg •m-2) (Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). It is estimated that if the 
current rate of prevalence continues, then 86.3% of US adults will be overweight or obese by 
the year 2030 (Wang, Beydoun, Liang, Caballero, & Kumanyika, 2008). Overweight and 
obesity are defined as abnormal or excessive fat accumulation that may impair health (CDC, 
2017). In normal, healthy individuals total body fat content is about 80-90% subcutaneous 
adipose tissue, about 6-20% visceral adipose tissue, and 7% adipose tissue 
compartmentalized in the retroperitoneal area. Health concerns particularly arise with 
excessive visceral adipose tissue which is an independent risk factor for diabetes, 
hypertension, and all-cause mortality (Bhupathiraju & Hu, 2016; Hayashi et al., 2004; Kuk et 
al., 2006; Nicklas et al., 2004). Additionally, a sexual dimorphism exists in fat distribution 
which affects cardio-metabolic disease risk. Males typically have an android phenotype 
characterized by a greater accumulation of visceral fat (Palmer & Clegg, 2015). Females 
generally have a gynoid phenotype with subcutaneous adipose tissue accrual around the 
gluteo-femoral region greater than visceral/abdominal adipose deposition. Increased 
lipoprotein lipase activity in the visceral region and its suppression by testosterone in the 
femoral region of men partially describe these sex differences in fat deposition (Arner, 
Lithell, Wahrenberg, & Bronnegard, 1991; Ramirez et al., 1997). Growth of fat mass can 
occur either by growth in volume of preexisting adipocytes, i.e. hypertrophy, or through 
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recruitment of new preadipocytes, i.e. hyperplasia (Tchoukalova et al., 2010). Studies in 
rodents suggest that subcutaneous depot increases by adipocyte hyperplasia while visceral fat 
accumulates by adipocyte hypertrophy (Wang, Tao, Gupta, & Scherer, 2013). These 
differences in adipose tissue expansion and sex differences in adipocyte deposition may 
affect certain body composition analysis techniques like bioelectrical impedance analysis.  
Air displacement plethysmography (ADP) is a body composition measurement 
technique that is less invasive than the gold standard Dual X-ray Absorptiometry (DXA). 
This system uses a measuring chamber of a known pressure and volume to calculate the 
volume of the subject. Poisson’s Law, the pressure-volume relationship at a constant 
temperature and humidity, and adjustments for thoracic lung volume are used to measure the 
volumetric displacement the subject imposes on the chamber (Ackland et al., 2012). Body 
density is then derived using other demographic measures like height and body mass in 
addition to body volume. Like hydro-densitometry, body density is then used to estimate a 
two-compartment body composition model consisting of fat-mass (FM) and fat-free mass 
(FFM). The BodPod made by Cosmed is a device utilizing ADP technology for 
measurements of body composition. The BodPod has been validated when compared to DXA 
and for test-retest reliability (Dewit, Fuller, Fewtrell, Elia, & Wells, 2000; Tucker, 
Lecheminant, & Bailey, 2014). Despite its validity in measurement of body composition, the 
BodPod is not commonly available for consumers because the procedure is often costly and 
takes time to endure.   
Bioelectrical impedance analysis (BIA) technology is widely used for body 
composition assessment because the equipment is normally portable, safe, and easy to use 
while less expensive than other techniques like DXA or ADP. BIA aims to derive fat mass 
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(FM) and fat-free mass (FFM) values from an estimation of body volume (BV) by sending an 
electrical current through the body (Ackland et al., 2012). Returning to the analyzer, the 
impedance of the electrical current can be determined.  
A principle the BIA uses is that of a cylinder’s volume where volume equals length 
multiplied by the cross-sectional area and impedance is inversely proportional to its cross-
sectional area. This principle also assumes the cylinder’s material is homogeneously 
conductive. However, the human body is not cylindrical, and tissues vary in conductivity 
(Kyle et al., 2004). To address this issue, engineers developed a multi-frequency BIA. Using 
both high and low frequencies allow the current to penetrate the cell membrane and 
consequentially account for both the extracellular fluid and intracellular fluid conductance 
from which an estimation of total body water (TBW) is determined. FFM can then be 
predicted from TWB due to FM only consisting of about 7% water (Kyle et al., 2004). 
However, as previously mentioned, adipocytes vary in number and size, thus the amount of 
water within FM varies and extrapolations present inherent error. Additionally, the 
deposition of insulated tissues within the body such as adipose tissues affects the impedance 
of surrounding conductive tissues according to the mixing theory (De Lorenzo, Andreoli, 
Matthie, & Withers, 1997).  
BIA technology has progressed over the last decade, however, a more recent study 
showed when compared to DXA percent error between methods was near 9% (Buffa, Mereu, 
Comandini, Ibanez, & Marini, 2014). Withings has developed a home bathroom scale called 
the BodyCardio that utilizes multi-frequency BIA technology to measure BM, FFM, and FM. 
The scale also wirelessly connects to a smart phone application where changes in body 
composition and weight can be tracked over time. While regular self-weighing and the use of 
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smartphone health applications can improve health outcomes, the Body Cardio has not been 
compared to gold standard measurement methods of body composition nor validated by an 
independent laboratory (Higgins, 2016; Zheng et al., 2015). 
 
Measurements of Arterial Health 
Arterial stiffness relates to the mechanical properties of arteries that subsequently 
affect cardiovascular health. In a healthy or young population arteries are more distensible 
when compared to an unhealthy or older population (Butlin et al., 2013). Arterial 
distensibility is important for health because it helps attenuate pulsatile flow and aligns 
timing of pressure waves returning to the heart for optimal coronary perfusion.   
The heterogeneity of the arterial tree, meaning the diminishing of elastic properties 
from the central to peripheral arteries, creates an increase in amplitude of the pressure wave 
known as pressure amplification. Frank, Bramwell, and Hill derived this propagative model 
of the circulatory system in the early 20th century. Their equation concluded that pressure 
amplification and the pulse wave’s velocity is inversely related to the distensibility and gave 
scientists a theoretical model to develop technology for measurement of pulse wave velocity. 
These studies created a large base of support and subsequently an expert consensus 
establishing carotid-to-femoral PWV (cf-PWV) as the gold standard for measurement of 
arterial stiffness (Mitchell et al., 2010; Townsend et al., 2015; Van Bortel et al., 2012).  Also, 
multiple meta-analyses have elucidated that measurement of cf-PWV improves CVD event 
and mortality prediction, independent of standard risk factors like hypertension, 
dyslipidemia, or high blood glucose (Ben-Shlomo et al., 2014; Mitchell et al., 2010; 
Vlachopoulos, Aznaouridis, & Stefanadis, 2010). 
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While multiple methods of cf-PWV measurement exist, the SphygmoCor devices by 
AtCor Medical are cited over 1000 times in peer-reviewed research articles and are validated 
against the ARTERY Society’s PWV validation guidelines (Butlin & Qasem, 2017; Butlin et 
al., 2013). The SphygmoCor XCEL uses applanation tonometry for high-frequency arterial 
wave form acquisition and volumetric displacement within a cuff for femoral pulse. The cf-
PWV can then be calculated by measuring the transit time between carotid and femoral pulse 
and dividing it by the pulse wave’s travel distance. This travel distance is estimated by 
measurement of several surface points along the body to most accurately determine carotid-
femoral length (Butlin & Qasem, 2017).  
Recently, Withings developed an advanced bathroom scale called the Body Cardio as 
a more convenient and less expensive alternative to devices like the SphygmoCor in 
measuring arterial stiffness. The BodyCardio uses ballistocardiography (BCG) and 
impedance plethysmography (IPG) to determine an aortic-leg pulse wave velocity (al-PWV) 
(Campo et al., 2017a). BCG measures slight weight variations due to left-ventricle ejection of 
blood and corresponds well to the opening of the aortic valve (Campo et al., 2017b). IPG 
measures blood volume changes at the measurement site and is used in the consumer scale to 
determine the arrival time of the pulse wave to the feet from the aortic valve. Subtracting the 
arrival time from the left ventricle ejection of blood and the pulse wave’s arrival time at the 
feet determination of al-PWV is possible. Comparison between SphymoCor XCEL and Body 
Cardio for PWV has already been completed and resulted in an “acceptable” agreement 
between devices according to the ARTERY society’s standards (Campo et al., 2017b; Van 
Bortel et al., 2012). However, no study has accounted for the gravitational effect by standing 
on a scale on al-PWV. Thus, the Body Cardio needs to be validated using this methodology.  
8 
 
 
Summary  
The purpose of this study was to assess the accuracy of a commercially available 
General Wellness Product for measures of body composition and arterial health when 
compared to laboratory gold standard measurements.   
It was hypothesized that there would be significant differences between devices for 
all measures of body composition and pulse-wave velocity. It was also hypothesized that 
there would be differences between devices attributable to sex.  
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Chapter 3 
Methods 
Participants 
Following approval of the study from Appalachian State University Institutional 
Review Board (IRB# 17-0023), twenty male and female adults 18-25 years of age were 
recruited. Prospective participants were contacted via face to face conversation or through an 
IRB approved email blurb. All subjects were apparently healthy, normotensive, and had no 
known cardiovascular, metabolic, or renal disease. Participants had a personal (iOS or 
Android) smartphone and service plan which they were able to use for this study. Exclusion 
criteria included chronic disease that might limit physical activity (e.g., peripheral arterial 
disease, effort angina, heart failure, and rheumatologic disorders), laboratory measurements, 
the use of the Withings devices (e.g. vision inadequate to read watch or smartphone displays, 
lack of dexterity required to use the devices) or receiving any antihypertensive medication.  
All participants were students from Appalachian State University. Descriptive statistics of the 
subjects included in this study are provided in Table 1. 
 
Table 1.  Subject Descriptive Statistics  
 
 
 
 
 N Min Max Mean SD 
Age (yrs.) 20 18 25 21.8 2.0 
Height (cm) 20 160.0 187.3 172.8 7.5 
Weight (kg) 20 51.0 94.5 66.8 12.2 
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Study Procedures 
Subjects were instructed to report to the Vascular Biology and Autonomic Systems 
Laboratory (VBASL) at Appalachian State University well-rested, fasted, and without having 
any stimulants twelve hours prior to testing. The investigator and subject reviewed an 
informed consent form which resulted in the subject’s signature if they agreed to the terms 
and procedures of the study. Anthropometric and demographic data, i.e. sex, date-of-birth, 
height and weight, was collected via medical history form and a calibrated scale and 
stadiometer. Next, subjects rested while seated for five minutes before blood pressure was 
manually and automatically recorded by a medical grade stethoscope and SphygmoCor, 
respectively. Manual auscultation was performed to ensure no technological discrepancies 
were present with the SphygmoCor. Subjects were subsequently assigned to either a body 
composition assessment by the Bod Pod or pulse-wave velocity measurement by the 
SphygmoCor in a random order. Before all weight and body composition measurements, the 
subject was required to remove all jewelry and excess clothing and additionally required to 
wear compression clothing such as spandex, compression shorts, or a sports bra. Subjects 
were instructed to wear a swim cap, breathe normally and to sit still while in the Bod Pod. 
Thoracic gas volumes were predicted using the BodPod software for body volume 
corrections. Two measurements were completed using the Bod Pod and unless the two were 
significantly different, i.e. more than one standard deviation, then no third measurement was 
made.  
 The subject was instructed to stand up next to the SphygmoCor with the Body Cardio 
in proximal distance. The researcher measured standing blood pressure after the subject had 
rested in the standing position for three minutes. Next, the femoral cuff was placed on the 
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subject and carotid to femoral artery distance was measured using a tape measuring device. 
Next the researcher began assessment of pulse wave velocity by placing a doppler pen via 
applanation tonometry on the subject’s carotid artery. Pulse wave velocity was measured 
three times and in between measurements the subject was instructed to stand onto the 
BodyCardio until successful measurement of body composition and pulse wave velocity were 
garnered. The BodyCardio was properly cleaned between subjects. 
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Chapter 4 
Results 
Statistical Analysis 
 Data was collected from each device’s particular software and the Withings’ 
“Healthmate” website and compiled into a secure database. The average of three pulse-wave 
velocity measurements and two of each body composition measurements were used for 
analysis. A Bland-Altman analysis was conducted for measures of pulse-wave velocity and 
body composition. Bias was calculated as the criterion-reference measurement minus the 
General Wellness Product measurement. A one-sample t-test was performed to acquire the 
mean difference and 95% confidence intervals for the Bland-Altman plots. Furthermore, 
regression analysis was performed to evaluate for proportional bias and Pearson correlation 
coefficient. Mean Absolute Percent Error (MAPE) presents the error as a percentage of the 
overall mean and indicates the degree of error. Additionally, a repeated measures ANOVA 
was conducted to analyze variance attributable to sex between devices.  
 
Pulse-Wave Velocity 
 The mean PWV and standard error for each device and sex are displayed in 
Table 2 as well as graphically displayed in Figure 1. The mean difference between devices 
was 0.68m/s and their respective 95% confidence intervals were (-0.16, 1.51) as shown in 
Figure 2. Regression analysis resulted in a Pearson correlation coefficient of 0.49 and 
evidence of proportional bias (p < 0.05). Analysis of variance showed no effect of sex on 
PWV measurement between devices. MAPE was calculated to be 9.7%.  
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PWV (w) PWV (r) 
Male 6.2±0.2 7.0±0.2 
Female 5.9±0.2 6.6±0.2 
Total 6.1±0.1 6.8±0.1 
Table 2. Pulse-Wave Velocity ± SE (m/s) 
* “r” = reference device “w” = Withings BodyCardio 
 
 
 
Figure 2. Pulse-Wave Velocity by Device and Sex 
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Figure 2. Mean Difference and 95% confidence intervals of PWV between devices.  
 
Body Mass 
 The mean BM and standard error for each device and sex are displayed in Table 
3 as well as graphically displayed in Figure 3. The mean difference between devices was -
0.11 kg and their respective 95% confidence intervals were (-0.41, 0.18) as shown in Figure 
4. Regression analysis resulted in a Pearson correlation coefficient of 0.47 and evidence of 
proportional bias (p<0.05). Analysis of variance showed no effect of sex on BM 
measurement between devices. MAPE was calculated to be 0.15%. 
 Table 3. Body Mass, Fat Mass, and Fat-Free Mass ± SE (kg).  
* “r” = reference device “w” = Withings BodyCardio 
 
BM (w) BM (r) FM (w) FM (r) FFM (w) FFM (r) 
Male 75.7±2.5 75.5±2.4 7.3±1.5 10.6±1.4 68.2±1.8 64.9±1.9 
Female 57.8±2.5 57.8±2.4 10.2±1.5 12.8±1.4 47.6±1.8 45.1±1.9 
Total 66.8±2.7 66.6±2.6 11.7±1.0 8.8±1.1 55.0±2.6 57.9±2.7 
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Figure 3. Body Mass by Device and Sex.  
 
Figure 4. Mean difference and 95% confidence intervals of BM between devices.  
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Fat Mass 
 The mean FM and standard error for each device and sex are displayed in Table 
3 as well as graphically displayed in Figure 5. The mean difference between devices was 
2.91kg and their respective 95% confidence intervals were (-2.91, 8.73) as shown in Figure-
6. Regression analysis resulted in a Pearson correlation coefficient of 0.16 and no evidence of 
proportional bias. Analysis of variance showed no effect of sex on PWV measurement 
between devices. MAPE was calculated to be 25.8%.  
 
Figure 5. Fat Mass by Device and Sex. 
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Figure 6. Mean difference and 95% confidence intervals of FM between devices 
 
Fat-Free Mass 
 The mean BM and standard error for each device and sex are displayed in Table 
3 as well as graphically displayed in Figure 7. The mean difference between devices was -
2.87kg and their respective 95% confidence intervals were (-9.04, 3.30) as shown in Figure 
8. Regression analysis resulted in a Pearson correlation coefficient is 0.06 and no evidence of 
proportional bias. Analysis of variance showed no effect of sex on PWV measurement 
between devices. MAPE was calculated to 5.6%.  
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Figure 7. Fat-Free Mass by Device and Sex.  
 
Figure 8. Mean difference and 95% confidence intervals of FFM between devices. 
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Chapter 5 
Discussion 
 The present study assessed the agreement between a consumer-based General 
Wellness Product and gold-standard laboratory measurements of arterial health and body 
composition. Body mass showed the strongest agreement between devices with a MAPE of 
0.15% whereas fat mass had the weakest agreement with a MAPE of 25.8%. Digital scales 
typically utilize a strain gauge to measure body mass instead of bioelectric impedance 
analysis which may explain the strength of agreement for body mass between devices. While 
there is not a consensus on an acceptable limit of error for body composition in comparison 
to gold-standard measurements this study’s findings beckon for further investigation into an 
acceptable range. One study has suggested that 1.5% or less percent error for body 
composition measures is acceptable when comparing the BodPod to DXA (Ball & Altena, 
2004). According to these guidelines, none of the body composition measurements from this 
study other than body mass would be deemed acceptable. 
 According to the ARTERY society’s expert consensus for accuracy of pulse-
wave velocity measurement, an “acceptable” accuracy rating is a mean difference of less than 
or equal to 1.0 m/s and a standard deviation of less than or equal to 1.5 m/s. The present 
study found the Withings BodyCardio to be in “acceptable” agreement with the AtCor 
Medical SphygmoCor for measurement of pulse-wave velocity with a mean difference of 
0.68 m/s and a standard deviation of 0.57 m/s in respect to the ARTERY society’s guidelines. 
A previous study had already demonstrated an “acceptable” accuracy between the 
BodyCardio and ShygmoCor but relied on self-reported height and did not account for the 
gravitational effects of standing upright on the cardiovascular system and pulse wave 
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velocity. This study was the first to show an “acceptable” accuracy between the devices 
while measuring subject height and accounting for the gravitational effects of standing 
upright while measuring pulse-wave velocity. The impact of these results are bolstered 
considering that pulse-wave velocity improves prediction of cardiovascular disease event and 
mortality independent of lifestyle and standard risk factors. Implications of having an 
affordable, portable, and accurate scale for measurement of pulse-wave velocity that can be 
monitored over time may include better cardiovascular health outcomes.  
 The number of subjects recruited was a limitation of this study. While the 
number of males and females were equivalent this study’s small sample size may provide 
explanation for the lack of observation of variance attributable to sex for pulse-wave velocity 
and body composition measures. Additionally, this small sample size may have hidden any 
proportional bias that would be pertinent to determining sensitivity. Another limitation of this 
study was the lack of control for hydration. Hydration status largely impacts measurement of 
body composition by bioelectrical impedance analysis (Buffa et al., 2014).  
 This study presented inaccuracies for fat mass and fat-free mass in the Withings 
BodyCardio when compared to gold-standard laboratory measurements in a young and 
healthy population. Furthermore, pulse-wave velocity was found to have an “acceptable” 
accuracy with the ARTERY societies guidelines. Moreover, the communication around these 
measurements of arterial health and body composition is important. While there are optimal 
ranges of body composition and pulse wave velocity for health, the dialogue between 
consumers and device manufactures needs to include information about device accuracy. 
Investigation to determine whether use of the BodyCardio’s corresponding phone application 
21 
 
“Healthmate” leads to prevention of cardiovascular disease or reduction of risk factors is 
needed.  
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